We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-13.46%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$161B
AUM Growth
-$27.5B
Cap. Flow
+$7.94B
Cap. Flow %
4.93%
Top 10 Hldgs %
22.83%
Holding
7,971
New
1,144
Increased
2,588
Reduced
2,287
Closed
1,065

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$517M
2
NXPI icon
NXP Semiconductors
NXPI
+$351M
3
ORCL icon
Oracle
ORCL
+$279M
4
PANW icon
Palo Alto Networks
PANW
+$268M
5
BSX icon
Boston Scientific
BSX
+$204M

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$517M
2
XOM icon
ExxonMobil
XOM
+$385M
3
CVE icon
Cenovus Energy
CVE
+$292M
4
PLAN
Anaplan, Inc.
PLAN
+$236M
5
PSX icon
Phillips 66
PSX
+$222M

Sector Composition

Rank Sector Weight
1 Technology 7.76%
2 Financials 7.66%
3 Healthcare 7.12%
4 Industrials 5.11%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LVACW
6651
CALL
DELISTED
LAVA Medtech Acquisition Corp. Warrants
LVACW
$9K ﹤0.01%
+77,500
New +$15.8K
IBER.WS
6652
CALL
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$9K ﹤0.01%
+114,500
New +$19.8K
TZPSW
6653
CALL
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$9K ﹤0.01%
110,000
– –
DRAYW
6654
CALL
DELISTED
Macondray Capital Acquisition Corp. I Warrant
DRAYW
$9K ﹤0.01%
90,833
– –
KAIRW
6655
CALL
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$9K ﹤0.01%
315,364
– –
HCARW
6656
CALL
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$9K ﹤0.01%
86,000
– –
TSIBW
6657
CALL
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$9K ﹤0.01%
71,633
-20,000
-22% -$5.46K
TLGA.WS
6658
CALL
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$9K ﹤0.01%
115,833
– –
BOAS.WS
6659
CALL
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$9K ﹤0.01%
54,332
– –
RCHGW
6660
CALL
DELISTED
Recharge Acquisition Corp. Warrant
RCHGW
$9K ﹤0.01%
125,000
– –
APRE icon
6661
Aprea Therapeutics
APRE
$11.5M
$8K ﹤0.01%
+513
New +$11.8K
PARAW
6662
CALL
Banzai International Warrant
PARAW
$104K
$8K ﹤0.01%
91,850
-1,150
-1% -$189
INUV icon
6663
Inuvo
INUV
$11.6M
$8K ﹤0.01%
+1,525
New +$6.79K
PALI icon
6664
Palisade Bio
PALI
$352M
$8K ﹤0.01%
+25
New +$12K
SLND.WS icon
6665
CALL
Southland Holdings Warrants
SLND.WS
$869K
$8K ﹤0.01%
30,000
– –
BCSAW
6666
CALL
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$8K ﹤0.01%
+101,650
New +$26K
LCW.WS
6667
CALL
DELISTED
Learn CW Investment Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
LCW.WS
$8K ﹤0.01%
100,000
– –
TWLVW
6668
CALL
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$8K ﹤0.01%
102,839
– –
NSTB.WS
6669
CALL
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$8K ﹤0.01%
83,220
– –
CFIVW
6670
CALL
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$8K ﹤0.01%
86,741
– –
SFRWW
6671
CALL
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$8K ﹤0.01%
75,000
-24,928
-25% -$5.96K
ATIP.WS
6672
CALL
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$8K ﹤0.01%
54,000
– –
ORIAW
6673
CALL
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$8K ﹤0.01%
50,000
– –
HTPA.WS
6674
CALL
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
$8K ﹤0.01%
60,000
– –
PHAS
6675
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$8K ﹤0.01%
13,501
-77,208
-85% -$73.9K
265 266
267
268 269

Similar funds

AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

Israel Englander's Q2 2022 Portfolio in Review

As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Israel Englander deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.

  • Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
  • Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
  • Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
  • Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
  • Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
  • Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
  • Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.